AVANT Immunotherapeutics Inc. (Nasdaq: AVAN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AVANT Immunotherapeutics Inc. (Nasdaq: AVAN)

AVAN 10.04

0.0%

Jun 12 9:41 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: TATRADER who wrote (433)	1/28/2003 1:56:51 PM
From: rrufff	of 513

I think your friend is using Genzyme standards in evaluating AVAN. I don't disagree with much of the analysis. However, it's not selling for 5 or 10, it's selling for a little over $1. Compare it with similar companies such as CPHD and it is favorable. (Actually, you can compare it to BDAL and CPHD but really getting into apples and oranges. My point is that you don't see a cash flow in developing bios. That's why it's selling at $1 and has a relatively low market cap.) I certainly wouldn't put non-speculative money into this. Recent PR indicated that company has enough cash to survive to the next stage. Gains will be PR driven for sure but projections of revenue and earnings will not be far behind. There has been a minimum of hype for a company in this stage and Una is well-respected and her testimony before Congress, etc., speaks for itself. I believe you'll see this double fairly soon and longer term it will hit a 52 week high between 3-4.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next